Safety and Efficacy of Intra-arterial Reteplase and Intravenous Abciximab in Patients with Acute Ischemic Stroke

Completed

Phase 2 Results

Summary of Purpose

To evaluate the safety and efficacy of escalating doses of a tissue-plasminogen activator (reteplase) used in conjunction with an antiplatelet agent (abciximab) in recanalizing occluded cerebral arteries in patients with acute ischemic stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 21 April 2009.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Centocor Inc.

Trial Design

Prospective, non-randomized, open-labeled trial.

Contacts

Not available